“As a result, cisplatin resistance can be overcome by co-administration of pyridoxine , and cisplatin-resistant cancer cells become exquisitely sensitive to killing by inhibitors of poly(ADP-ribose) polymerase, starvation, and antimetabolites targeting nucleotide biosynthesis.”